Results 321 to 330 of about 104,235 (402)

Limited Diagnostic Yield of Routine Gastroscopy in FIT-Positive Patients. [PDF]

Diagnostics (Basel)
Khader M, Abu Baker F, Delgado JS, Yitzhak A, Guterman R, Elhayany R, Bakshi O, Klaitman V, Braun T, Abu-Freha N, Artoul R.   +10 more
europepmc   +1 more source

Isolated Anti‐SS‐A Antibody Seropositivity as a Poor Prognostic Factor in Systemic Sclerosis: Insights From a Cohort of 307 Cases

The Journal of Dermatology, Volume 53, Issue 1, Page 41-53, January 2026.
ABSTRACT Systemic sclerosis is an autoimmune disease characterized by vasculopathy, fibrosis, and immune dysregulation. Anti‐SS‐A antibodies (anti‐SSA) have been reported to confer severe clinical manifestations in some Western and Japanese cohorts. We aimed to determine whether anti‐SSA seropositivity affects clinical outcomes in Japanese patients. We
Nana Ishida, Kazuki M. Matsuda, Hirohito Kotani, Hayakazu Sumida, Shinichi Sato   +4 more
wiley   +1 more source

Acute Necrotizing Esophagitis Following a 44-Hour Refractory Food Bolus Impaction. [PDF]

Cureus
Fujii Y, Hayashi D, Kitazawa M, Doi A, Nakamatsu D, Matsumoto K, Yamamoto M, Fukui K, Nishida T.   +8 more
europepmc   +1 more source

A Liquid Thickener Presentation Format for the Therapeutic Management of Dysphagia—A Promising Step Forward in Addressing the Challenges Associated With Thickened Fluids in Swallowing Disorders?

International Journal of Language &Communication Disorders, Volume 61, Issue 1, January/February 2026.
ABSTRACT Introduction Thickening fluids in routine care of patients with Oropharyngeal dysphagia (OD) can improve swallow safety but may be counteracted by reduced palatability, enjoyment, embarrassment, and isolation related to drinking thickened fluids (TFs).
Natascha Ullrich, Brenda Mossel, Sue Pownall, Jo Burke, Helena Perry, Heather Robinson, John Stephenson   +6 more
wiley   +1 more source

Causal Relationships Between Gastroesophageal Reflux Disease and Myocardial Infarction: Insights From Univariable and Multivariable Mendelian Randomization Analyses

Annals of Human Genetics, Volume 90, Issue 1, Page 52-62, January 2026.
ABSTRACT Background Observational studies have indicated that gastroesophageal reflux disease (GERD) is connected to myocardial infarction (MI). Nonetheless, the question of causality in these relationships remains unresolved, given the potential influence of confounding variables.
Xiaoya Zheng, Teng Hu, Tianxiang Fang, Pengpeng Su, Yingsong Wang, Ning Huangfu   +5 more
wiley   +1 more source

Comparative Efficacy and Safety of Swallowed Topical Corticosteroids in Eosinophilic Esophagitis: A Network Meta-Analysis. [PDF]

J Clin Med
Lucendo AJ, Arias Á, Álvarez-Bueno C, Martínez-Vizcaino V, Redondo-Cavero I, EUREOS EoE Guidelines Committee.   +5 more
europepmc   +1 more source

Feasibility and efficacy of hypofractionated proton reirradiation for recurrent lung cancer. [PDF]

Int J Part Ther
Karp JM, Banson KM, Cahlon O, Tsai HK, Lee JY, Yan SX, Darwish H, Sine K, Mah D, Chon BH, Cooper BT.   +10 more
europepmc   +1 more source

Mapping the Burden and Risk Factors of Allergic Diseases and Asthma Among Aboriginal and Torres Strait Islander People: A Scoping Review

Clinical &Experimental Allergy, Volume 56, Issue 1, Page 15-29, January 2026.
Our study reveals Aboriginal and Torres Strait Islander people have a high allergy burden, with asthma the most prevalent; yet they remain under‐represented in research. ABSTRACT Allergic diseases and asthma are significant public health concerns in Australia and globally.
Desalegn Markos Shifti, Erin Pitt, Lesley Versteegh, Rani Scott Farmer, Catherine J. Hornung, Victoria Gibson, Diane Maresco‐Pennisi, Shyamali C. Dharmage, Anne B. Chang, Jennifer J. Koplin   +9 more
wiley   +1 more source

Improving image-retrieval performance of foundation models in gastrointestinal endoscopic images. [PDF]

Front Med (Lausanne)
Kim K, Park J, Kim SH, Hwang Y.
europepmc   +1 more source

Relative efficacy of GLP‐1 and GLP‐1/GIP receptor agonists in the prevention of alcohol‐use disorders using a target trial emulation approach

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 137-150, January 2026.
Abstract Aims There is growing evidence that the GLP‐1 system is implicated in alcohol and other substance use disorders, and that GLP‐1‐based therapies may have therapeutic relevance in alcohol use disorder (AUD). We aimed to determine the impact of GLP‐1 based therapies on incident AUDs in a real‐world setting in patients with T2D.
Alex E. Henney, David R. Riley, Megan Heague, Carl A. Roberts, Theresa J. Hydes, Matthew Anson, David M. Hughes, Uazman Alam, Daniel J. Cuthbertson   +8 more
wiley   +1 more source